When my husband told me today that Merv Griffin had died, I was running on my treadmill, doing my part to pound out any chance that cancer will pay me a return visit. On my MP3 player the song Bad Day by Daniel Powter was blaring. Sweating, halfway through my second mile and feeling quite strong, I heard the words -- "Did you hear Merv Griffin died?"

No, I had not yet heard. All I was hearing were these lyrics:

You had a bad day
The camera don't lie
You're coming back down and you really don't mind
You had a bad day
You had a bad day

The seven cancer thoughts I present to you today are purely random. They are not linked by theme or category. There is no rhyme or reason for my choosing them. And they do not belong with one another for any other reason than this: they all come directly from my very own head and are somehow related to the disease that lingers in my thoughts for most minutes of most days. Here they are:

1. Vanity is merely a six-letter word. It's certainly not as important after cancer as it is before. I admit vanity played a role in my life prior to my breast cancer diagnosis and still, it's with me to some degree. But more important than vanity now is waking each morning and realizing I'm alive. I don't want to lose weight to look ultra thin. I choose to reach an ideal weight because I want to be healthy. I don't want a tan. I want skin that is free from damage. My clothes? I want them to fit and feel comfortable. That's it.

2. Normal is a thing of the past. It's funny how I worked so hard to look normal after cancer struck (note: here's vanity rearing its head). Prior to losing my hair to chemotherapy, I worked hard at matching my long, straight, blond hair to a wig that would become my disguise for five months. I found the perfect replica of what would eventually tumble from my scalp, and I wore it proudly. A neighbor who knew I was receiving chemotherapy once told my sister, "That's so great Jacki didn't lose her hair." I looked that much like normal, people didn't know anything had changed. Little did I know change was right around the corner. When my hair grew in, it was dark and curly. Not even close to normal.

Gardening is good for the soul. I'm sure of it. It did wonders for my grandma, who planted and flowered and blossomed for most of her life and long after her rounded back and arthritic fingers told her to stop. She just couldn't help herself -- the fruits of the earth brought her such joy that the toll hard labor took on her body was somehow worth every trace of dirt that crumbled beneath her fingertips.

In my own small way, I can't resist either. I'm no lifelong gardener or anything. I'm more of a spur-of-the-moment kind of girl. And I haven't a green thumb on either of my hands. My flowers always seem to die. Because no matter how much I love them at the beginning of the warm season, I end up neglecting them.

I tell my husband every year, "Please remind me not to buy flowers this year." It just seems silly to spend so much money only to toss my dead blooms after they wither and shrivel. So my husband reminds me. And I go right back out and buy more. Like I did today.

I spent about an hour with my little boys shoveling dirt and arranging red and orange and yellow and white flowers in all sorts of pots. It was a priceless hour -- although really it cost me about 60 bucks. It was refreshing and rejuvenating and in a way, healing.

I know the effects of today's flower therapy will fade, just as the flowers themselves will fail to thrive. But I also know I will do it all again next year. Because it's good for my soul. And I just can't resist.

Business is business. Maybe it's about making a difference in the world of consumers but mostly, it's about making money. I get that -- and if I owned my own company and offered some sort of product, surely my goal would be to reap a financial reward. And if I wanted to increase my reward, I guess I would consider new markets, new advertising, and new techniques for hauling in loads of cash.

So I see what's going on with the new Camel No. 9 cigarettes, in their hot-pink fuscia and minty-teal green packages with the slogan Light and Luscious. I understand this brand is targeting female smokers with enticing wording that Camel maker R.J. Reynolds executives say is meant to suggest dressed to the nines, putting on your best. I even get that it's a pretty savvy strategy. But somehow, it all seems so wrong.

In a world where more women die of lung cancer than breast cancer -- by a large margin -- how can anyone, even business people whose sights are set on profits, feel OK with the decision to encourage women to smoke?

Think about these passages that just recently published in a New York Times article:

Wall Street analysts praise the introduction of Camel No. 9, in regular and menthol flavors, as a further step by the R. J. Reynolds, a unit of Reynolds American, toward a new marketing strategy. The goal is to refocus on the biggest, most popular -- and most profitable -- brands, which include Kool as well as Camel.

"What we're about is giving adult smokers a choice," says one executive, "with products we believe are more appealing than existing products." The introduction of Camel No. 9 is part of plans to "focus on products that are 'wow,' " she added, "that add fun and excitement to the category."

Fun and excitement? Believe me, there's nothing fun and exciting about cancer. Now if I could only package that truth and market it to the world. I suspect I'd be a rich woman -- and I don't mean financially.

Today I offer you not so much a Thought for the Day but a Question for the Day. Before I ask my pressing question, though, I want you to consider this story.

Diagnosed with a rare malignant melanoma on her retina in 2001, Ann Guthrie, a South Carolina wife and mother of two grown sons, endured radiation and chemotherapy. The treatments shrunk Guthrie's tumor, but another mass appeared two years later, forcing the removal of her right eye.

At about the same time Guthrie lost her eye, cancer was discovered in her lungs. It was inoperable. Then cancer landed in her brain. And now, without any approved treatment avenues, Guthrie is out of options.

Like many people with terminal illnesses, this woman is willing to try just about anything -- a clinical trial, experimental drugs, risky treatments -- to extend her life. If she's going to die anyway, why not? She just might live longer. And if she doesn't, she could at least help advance science by offering herself up as a sort of guinea pig.

While the Food and Drug Administration (FDA) has proposed changes that would make it easier for patients to access options like these, it's just not that simple right now.

There are ethical issues -- like weighing the needs of people who think anything is better than death against the need of society to prove drugs and treatments work safely. The only way to ensure a sort of balance is through clinical trials -- and letting anyone participate in clinical trials, for example, would make the results harder to interpret.

And there are medical and legal risks. What if terminally ill patients end up in worse shape after a treatment with an experimental drug, for example? What if the FDA or a physician is considered responsible for adverse drug reactions?

Denying terminal patients their last bits of hope is difficult. "It's a hard discussion to have with a patient and his family," says one doctor. "There's a lot of tears. We all would love to be able to get them access to some form of therapy."

And now for my question:

What do you think about terminally ill cancer patients and their access to anything that might extend -- or save -- their lives?

It's been so long I can barely remember the cause of the family rift that kept me separated from an aunt, an uncle, and cousins for many years. All that remains clear is that a once-close family split apart because of disagreement and hurt feelings and that my grandma -- the glue that held this family together for more than 50 years -- was heartbroken. She did everything she could to repair the damage of her splintered family. But despite begging, pleading, and continued prayers, reconciliation seemed impossible -- until it became evident this sweet woman was about to die.

The progress was slow and began with a rallying of family members at my grandma's bedside. She was somewhat incoherent at the time, and I'm not quite sure if she realized her broken family was on the mend. But I hope she knows, in some heavenly way, that she is the one who ultimately brought everyone together.

After her passing, we all gathered for her memorial service. We took turns spreading her ashes at a tree planted in her honor. We talked and visited and laughed and ate. We broke the ice and opened the door for further interaction. It was refreshing to mourn the loss of Gram without overriding tension and conflict.

I'm not sure if family relations would have continued without what happened next. I suspect we may have all returned to our lives and gone our separate ways, happy we had reconnected but still missing the closeness we once experienced. But then cancer entered our lives, shocked us all, and gave us all reason to stay in touch.

I was diagnosed with breast cancer not long after my grandma died. And the same people who came to her bedside came to my rescue in ways I never would have imagined in the heat of battle. The same people who for years were absent from my life were the ones offering me support and encouragement and love. They helped me get better.

Once I was better, life returned to a somewhat normal routine. And maybe we would have routinely slipped back into our selfish ways. But illness struck again, requiring we all step back up to the plate.

My uncle, who has lived with diabetes for many years, was faced this year with losing his foot. Thankfully, he found specialists who gave him hope and reason to travel every month for several months to a clinic in my city, where eight family members live and where options never before available to him became a reality -- both medically and personally.

My uncle is doing well, walking on his foot with the aid of a brace. And our family is doing well, as a result of frequent visits, lunches, and continued laughs.

It took death and disease to bridge the gap that existed for much too long between the members of my family. And just this weekend, after spending a glorious weekend with my long-lost cousins, I realized we have possibly arrived back where we once started -- before whatever led to our disagreement and hurt feelings drove us apart.

I believe Gram is smiling down upon us at this very moment, content at last that her three beautiful children -- and their children and their children -- are again a happy family.

Some scientists believe that surgery to remove a breast tumor may actually help the cancer spread and have recently reported that this same belief may be the exact reason black women are more likely to die of breast cancer.

There is apparently a widespread belief in parts of Africa and the United States that removing a tumor hastens death.

"I must say that I am sure there is more to this than just a myth," said Michael Retsky of Children's Hospital and Harvard Medical School in Boston, who shares his opinions in the International Journal of Surgery.

Retsky still urges any woman with breast cancer to have her tumor removed. And he says chemotherapy is such standard practice for any cancer threatening to spread. It's a safety net of sorts to catch the cells that get away. So if surgery causes cancer to spread, then in theory, chemotherapy should stop the spread.

Retsky, who is not suggesting any change in clinical practice, thinks the subject needs far more research. American Cancer Society experts, who tend to question this theory, agree.

"Whether or not the theory is correct, I have difficulty with the logic that they employed to get there," said oncologist Dr. Len Lichtenfeld of the American Cancer Society who says women should never delay treatment for breast cancer.

Retsky believes that perhaps surgery, by wounding the body, causes it to produce growth factors that fuel the growth of other, tiny tumors. Or maybe a primary tumor secretes some sort of factor that holds the other tumors in check. When the main tumor is removed, the smaller tumors grow.

But it could be that surgery does not cause a spread at all – and that any belief of this nature has no connection with breast cancer tendencies in black women. It may be that black women just have a genetic predisposition for more aggressive forms of the disease.

A friend of mine with breast cancer just sent out an update e-mail to friends and family. She began her message with an apology for her recent lack of communication. But she assured us all that she's been out of the loop not because she's felt sick or tired. It's because she's been too busy with normal life. And that's a good thing, she says.

This friend wasn't so sure how she would fare -- both physically and emotionally -- when she was first diagnosed with cancer. But she seems to have done a champion's job of rolling with the punches. Sure, she's had ups and downs. But she is overwhelmingly positive and hopeful. And jumping off my computer screen as I read her e-mail were at least seven bits of hope that tell me she is doing just fine despite all that is unbelievably hard about breast cancer.

My friend just had her first infusion of Taxol. A breeze, she calls it. One. So easy on her body -- two -- that she headed right out and took her daughter communion dress shopping. Her little love looked beautiful, she wrote. Like a mini-bride. The mother of the mini-bride then -- three -- turned a sad moment into a comforting one when her daughter asked, "Mommy, who do you think will bring me wedding dress shopping?"

Cancer patients who have heart attacks are typically not treated with a course of life-saving aspirin because of the belief that these patients might experience lethal bleeding.

This belief is now under dispute and researchers at The University of Texas M. D. Anderson Cancer Center say that without aspirin, the majority of these patients will die. Their arguments, subject of a recent study, will be published in the February 1 issue of the journal Cancer.

Aspirin has been viewed as harmful because of its tendency to thin blood. Because cancer patients can experience low platelet counts and abnormal clotting, aspirin has been considered a contraindication. But this study found that nine of 10 cancer patients with low platelet counts who experienced heart attacks and who did not receive aspirin died. Only one patient died, however, in a group of 17 cancer patients who received aspirin.

This conclusion -- that aspirin helps people with cancer just as it does for people without cancer -- may help medical professionals determine guidelines for treatment of heart attacks in cancer patients. Because right now, physicians are uncertain about how to balance treatment for both conditions.

The United Arab Emirates (UAE) is the first country in the Middle East to acquire the cervical cancer vaccine, Gardasil.

Comparisons of cervical cancer statistics for the years 1998 through 2005 show incidences of the disease tripling during this span of time. So acquisition of the vaccine is a true blessing for the women of this country.

"We are proud to have placed the UAE on the map with leading countries such as the US, Australia and EU by approving Gardasil, the first breakthrough vaccine that prevents the cancer," said Dr Wisam Haddadin, Franchise Manager, Gulf Region, Merck Sharp & Dohme.

Gardasil, distributed by Merck, Sharp, & Dohme, is now available in more than 33 countries for the prevention of cervical cancer, most commonly caused by HPV (human papilloma virus). About 2.3 million women are currently diagnosed with cervical cancer worldwide. About 800 women die of the disease every day.

Canadian and international researchers suspect adding a high-dose vitamin D pill to chemotherapy might improve treatment for advanced prostate cancer. So they are recruiting 1,000 men for a two-year clinical trial in order to investigate their suspicions. Currently, there is little to offer patients who no longer respond to to standard treatment.

The trial will test the pill calcitriol -- a biologically active form of vitamin D and naturally occurring hormone -- to see how it works in combination with the chemotherapy drug docetaxel. Precautions will be taken to minimize side effects that can occur with high-dose supplements.

The Canadian Cancer Society estimates that 20,700 men in Canada will be diagnosed with prostate cancer this year. About 4,200 of these men are expected to die from the disease.

One common thread woven into overall cancer prevention and survival is this -- exercise.

One hour of daily vigorous exercise -- or two hours of less strenuous activity -- is now linked to a lower risk of colon cancer, according to the results of a recent study.

Jogging, pumping iron, swimming, and even housecleaning can do the trick, as demonstrated by research conducted with 413,000 people in 10 European countries.

Of those studied, people with the highest level of exercise were 22 percent less likely to develop cancer and 35 percent less likely to develop tumors on the right side of the colon. Those of normal weight enjoyed a greater benefit, but exercise was also beneficial for the overweight and obese. Exercise did not have a protective effect against rectal cancer.

This research -- helping to support the fact that about 70 percent of colon cancer cases can be prevented by changes in diet and exercise -- is significant because of the large sample size and the different levels of activity observed across the borders.

Colon and rectal are among the most common cancers in developed countries. More than 940,000 cases are diagnosed each year. About 492,000 people die from the illness.

A new compound developed by the healthcare company Abbott might have the power to end the prolonged life of cancerous tumor cells.

The compound, ABT-737, is being researched by experts at Walter and Eliza Hall Institute, Melbourne's world leading medical research body. And the drug is showing great promise.

Melbourne scientists discovered in 1989 how to keep cells alive. Then they determined how cancer cells are formed. After months of assessment, scientists believe ABT-737 could turn a switch back on in the body to ensure tumor cells die.

"Rather than attempting to poison the rogue cells, the new drug attempts to reactivate the normal cell death program that failed to kill the unwanted cells on cue," said one researcher. "ABT-737 is a switch flicker that kicks the cell death machinery into action."

Cervical cancer was once the most common cancer in women. But between 1955 and 1992, the number of cervical cancer deaths dropped by 74 percent -- thanks to increased use of the Pap test, a screening tool that can find changes in the cervix before cancer develops and can also detect cancer in its most curable stage. The Pap test is still widely used. And the cervical cancer death rate continues to drop four percent every year.

In 2006, about 9,700 new cases of invasive cervical cancer will be diagnosed in the United States. About 3,700 women will die from the disease. Non-invasive cervical cancer is believed to be four times more common than the invasive form of the disease. Nearly all of these cases can be cured.

Cervical cancer typically occurs in women between the ages of 35 and 55 and rarely in women under the age of 20. It affects mostly Hispanic women, and African-American women develop the disease 50 percent more often than non-Hispanic white women. Women most as risk for cervical cancer are smokers, those with HIV or chlamydia infections, those with diets low in fruit and vegetable consumption, those who between 1940 and 1971 took the hormonal drug DES, and those who have taken oral contraceptives for extended periods of time. Women who have had multiple pregnancies, have a family history of the disease, and have a low socio-economic status are also at risk. Those most at risk, however, are women with human papilloma virus.

Human papilloma virus (HPV) is the most common risk factor for cervical cancer, and some experts believe a woman must have HPV to contract cervical cancer. There are 100 different types of HPV, 13 of which are likely to cause cervical cancer through sexual contact. There are usually no symptoms of HPV, but possible signs of cervical cancer can include vaginal bleeding, unusual discharge, pelvic pain, and pain during sexual intercourse.

There are two ways to stop cervical cancer. First, women can protect themselves against HPV. Protection comes in the form of delaying sexual activity, limiting the amount of sexual partners and their partners, using condoms (thought to be 70 percent effective) and receiving the cervical cancer vaccine, recommended for use in females ages 11-26. The vaccine is most effective for women who have never been sexually active. Second, women can receive regular Pap tests in order to catch pre-cancers. Pap tests are recommended for women three years after their first sexual encounter and before the age of 21 -- and then every year after that.

An abnormal Pap test typically prompts a colposcopy -- a technique that uses a scope to examine the cervix. Diagnosis usually stems from a combination of other scoping methods, pelvic exams, imaging tests, and biopsies used to confirm the presence of cancer and to stage the disease. Stages range from 0-4.

For non-invasive cervical cancer, surgery -- ranging from removal of the cancerous tissue to hysterectomy -- may be the only treatment necessary. For invasive forms of the cancer, surgery is often followed by radiation and chemotherapy. Women interested in preserving their fertility should discuss options with their physicians.

The state of cervical cancer has come a long way over the years. And this year, two critical developments emerged. In June 2006, the FDA approved the first drug for late-stage cervical cancer. The drug, Hycamtin, is recommended for use in combination with chemotherapy. Also is June, the cervical cancer vaccine, Gardasil, was released. Both developments are monumental -- and both will undoubtedly help decrease the already-dropping cervical cancer death rate.

For more information about cervical cancer, visit the following sites:

American Cancer Society
Mayo Clinic
Medline Plus
National Women's Health Information Center

In 2006, 174,470 people will be diagnosed with lung cancer in the United States. About 92,700 men and 81,770 women will develop the disease -- the leading cause of cancer death among both men and women.

An estimated 162,460 men and women will die of lung cancer this year, accounting for 28 percent of all cancer deaths and taking more lives than colon, breast, and prostate cancers combined. While most people diagnosed with lung cancer will die within the first two years of diagnosis -- this has not changed in 10 years -- some people are cured. There are currently about 333,000 long-term survivors.